HAYDEN RAMSEY: Open Payments
NPI 1891449278 · METAIRIE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,318 in 111 payments from 39 companies in 2025. Trend: 2023 $956 · 2024 $3,168 · 2025 $2,318
Food & beverage: $2,318
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $224 |
| Celgene Corporation | 8 | $193 |
| Incyte Corporation | 7 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $121 |
| GlaxoSmithKline, LLC. | 5 | $95 |
| GENZYME CORPORATION | 4 | $94 |
| Janssen Biotech, Inc. | 5 | $88 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $88 |
| Ipsen Biopharmaceuticals, Inc | 3 | $80 |
| Daiichi Sankyo Inc. | 3 | $77 |
Products named: REBLOZYL, KISQALI, SARCLISA, Somatuline Depot, JAKAFI, CABOMETYX, JEMPERLI, LIBTAYO.
Industry payments across LA — which companies pay providers there.
